Notification of the difference between the earnings forecast and the disclosed actual results for the second quarter of the fiscal year ending December 2026. The divergence is attributed to changes in revenue outlook in the regenerative medicine support business.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7776","jir_company_name":"Ceres Seed Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/7776-20260813-03.pdf","jir_short_summary":"Notification of the difference between the earnings forecast and the disclosed actual results for the second quarter of the fiscal year ending December 2026. The divergence is attributed to changes in revenue outlook in the regenerative medicine support business.","jir_summary":"### Section Heading\nThis notice is a disclosure regarding the difference between the earnings forecast and actual results for the second quarter of the fiscal year ending December 2026. Specific causes include timing of revenue recognition and reallocation of costs in the regenerative medicine support business. While the figures for revenue and profit items are unknown, the factors behind the difference and the company\u2019s policy for future disclosure are explained.\n\n### Section 2 Heading\nThe reason for the difference includes delays or advances in revenue recognition in the regenerative medicine support business. As for future disclosure policy, there may be recalculation of outlook and additional disclosures. The impact on investors is largely uncertain, and concrete figures are not currently provided.","jir_financial_highlights":"Revenue: Unknown (Unknown)\nOperating income: Unknown (Unknown)\nOrdinary income: Unknown (Unknown)\nNet income attributable to owners of the parent: Unknown (Unknown)","jir_category":"","jir_hashtags":"#CeresSeed, #DisclosureUpdate","jir_key_figures":"Specific amounts of the differing figures are unknown\nThe reason for the difference stems from the regenerative medicine support business\nFuture disclosure plans or potential revisions are not yet determined","jir_meta_title":"Ceres Seed \u2014 Notice Regarding the Difference Between Earnings Forecast and Actual Results for the Second Quarter of the Fiscal Year Ending December 2026","jir_meta_description":"Notice regarding the difference between the earnings forecast and actual results for the second quarter of the fiscal year ending December 2026 for Ceres Seed. Explanations of the main causes and the timing of future disclosure policies and outlook updates.","jir_og_title":"Ceres Seed \u2014 Notice Regarding the Difference Between Earnings Forecast and Actual Results","jir_og_description":"Ceres Seed discloses the difference between the earnings forecast and actual results for the second quarter of the fiscal year ending December 2026. Key factors of the difference and future disclosure policy are summarized.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[]","ir_related_company":59075,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-103589","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n